Today's Information

Provided by: WELLELL INC.
SEQ_NO 3 Date of announcement 2022/06/20 Time of announcement 17:50:30
Subject 
 Announcement for Elected Directors
on Behalf of Wellell Inc.
Date of events 2022/06/20 To which item it meets paragraph 6
Statement 
1.Date of occurrence of the change:2022/06/20
2.Elected or changed position (Please enter institutional director,
institutional supervisor, independent director, natural-person director or
natural-person supervisor):institutional supervisor & independent director
3.Title and name of the previous position holder:
 (1)Director: Representative of Yasheng Investment and Development Co., Ltd.
             : Daniel Lee;
 (2)Director: Representative of Yasheng Investment and Development Co., Ltd.
            : Charles Liu;
 (3)Director: Representative of CDIB Capital Growth Partner L.P.:
            : Eddie Wei
 (4)Director: Representative of National Development Fund, Executive Yuan
            : Chi-Kung Ho
 (5)Independent Director: Wan-Ying Lin
 (6)Independent Director: William Wang
 (7)Independent Director: James Wang
 (8)Independent Director: Peter Lin
 (9)Independent Director: Hsiung-Ching Lee
4.Resume of the previous position holder:
 (1)Representative of Yasheng Investment and Development Co., Ltd.
            : Daniel Lee (Wellell's President)
 (2)Representative of Yasheng Investment and Development Co., Ltd.
            : Charles Liu (Wellell's Vice-President)
 (3)Representative of CDIB Capital Growth Partner L.P.:
            : Eddie Wei (Amtran's Independent Director)
 (4)Representative of National Development Fund, Executive Yuan
            : Chi-Kung Ho (Kaohsiung Medical University professor)
 (5)Independent Director: Wan-Ying Lin (National Chengchi University
            associate professor)
 (6)Independent Director: William Wang (Crystalvue's Chairman of
                           the Board)
 (7)Independent Director: James Wang (HonHai's Independent Director)
 (8)Independent Director: Peter Lin (The head of Hemu Investment Ltd.)
 (9)Independent Director: Hsiung-Ching Lee( Jiu Zhen Nan's
                          Chairman of the Board
5.Title and name of the new position holder:
 (1)Director: Representative of Yasheng Investment and Development Co., Ltd.
            : Daniel Lee;
 (2)Director: Representative of Yasheng Investment and Development Co., Ltd.
            : Charles Liu;
 (3)Director: CDIB Capital Growth Partner L.P.
 (4)Director: Representative of National Development Fund, Executive Yuan
            : Chi-Kung Ho
 (5)Independent Director: Wan-Ying Lin
 (6)Independent Director: William Wang
 (7)Independent Director: James Wang
 (8)Independent Director: Peter Lin
 (9)Independent Director: Hsiung-Ching Lee
6.Resume of the new position holder:
 (1)Representative of Yasheng Investment and Development Co., Ltd.
            : Daniel Lee (Wellell's President)
 (2)Representative of Yasheng Investment and Development Co., Ltd.
            : Charles Liu (Wellell's Vice-President)
 (3)CDIB Capital Growth Partner L.P.
 (4)Representative of National Development Fund, Executive Yuan
            : Chi-Kung Ho (Kaohsiung Medical University professor)
 (5)Independent Director: Wan-Ying Lin (National Chengchi University
            associate professor)
 (6)Independent Director: William Wang (Crystalvue's Chairman of
                           the Board)
 (7)Independent Director: James Wang (HonHai's Independent Director)
 (8)Independent Director: Peter Lin (The head of Hemu Investment Ltd.)
 (9)Independent Director: Hsiung-Ching Lee( Jiu Zhen Nan's
                          Chairman of the Board)
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):term expired
8.Reason for the change:term expired
9.Number of shares held by the new position holder when elected:
 (1)Representative of Yasheng Investment and Development Co., Ltd.
            : Daniel Lee (10,566,760 shares)
 (2)Representative of Yasheng Investment and Development Co., Ltd.
            : Charles Liu (10,566,760 shares)
 (3)CDIB Capital Growth Partner L.P. (11,526,000 shares)
 (4)Representative of National Development Fund, Executive Yuan
            : Chi-Kung Ho (6,000,000 shares)
 (5)Independent Director: Wan-Ying Lin (0 share)
 (6)Independent Director: William Wang (0 share)
 (7)Independent Director: James Wang (0 share)
 (8)Independent Director: Peter Lin (6,000 shares)
 (9)Independent Director: Hsiung-Ching Lee(0 share)
10.Original term (from __________ to __________):2019/06/18~2022/06/17
11.Effective date of the new appointment:2022/06/20
12.Turnover rate of directors of the same term:term expired,not applicable
13.Turnover rate of independent directors of the same term:term expired,n/a
14.Turnover rate of supervisors of the same term:N/A
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):term expired,not applicable
16.Any other matters that need to be specified:None

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

APEX MEDICAL Corp. published this content on 20 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 June 2022 10:03:04 UTC.